Cargando…
Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases
BACKGROUND: Diabetes is one of the most prevalent chronic diseases, and its prevalence is predicted to increase in the next two decades. Diabetes imposes a staggering financial burden on the health care system, so information about the costs and experiences of collecting and reporting quality measur...
Autores principales: | Esposti, Luca Degli, Saragoni, Stefania, Buda, Stefano, Sturani, Alessandra, Esposti, Ezio Degli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658432/ https://www.ncbi.nlm.nih.gov/pubmed/23696709 http://dx.doi.org/10.2147/CEOR.S41846 |
Ejemplares similares
-
Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients
por: Degli Esposti, Luca, et al.
Publicado: (2014) -
Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting
por: Degli Esposti, Luca, et al.
Publicado: (2014) -
Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years
por: Esposti, Luca Degli, et al.
Publicado: (2010) -
Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
por: Esposti, Luca Degli, et al.
Publicado: (2011) -
Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a ‘real-world’ retrospective cohort study
por: Degli Esposti, Luca, et al.
Publicado: (2016)